Olfaction Disorders
18
2
3
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.6%
1 terminated out of 18 trials
88.9%
+2.4% vs benchmark
6%
1 trials in Phase 3/4
0%
0 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (18)
Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity
Olfactory Training on Smell Dysfunction Patients in HK
COVID-19: Post-covid Olfactory Disorders Assessment
Sodium Citrate in Smell Retraining for People With Post-COVID-19 Olfactory Dysfunction
Study of EEG and Nasal Stimulus in Olfactory Disorders
Olfactory and Taste Changes During Fasting Mimicking Diet (FMD)
GnRH Therapy on Cognition in Down Syndrome
Rapid Screening for Olfactory Disorders in Covid-19 Infection
Intranasal Injection of PRP Versus Saline for Treatment of Olfactory Dysfunction
"Platelet Rich Plasma for the Management of Post-Viral Olfactory Dysfunction.
Olfaction and Inflammation in Chronic Rhinosinusitis With Nasal Polyps
Morphological Abnormalities of the Olfactory Bulb on MRI and Olfactometry in Anosmic Versus Normosmic COVID-19 Patients
Evaluation of Two Methods of Olfactory Rehabilitation in Post-viral Loss of Smell: Classic and Intensive
Computerized Olfactory Test - Alzheimer Disease Mild Stage
Olfaction Disorders in Patients Included in The Trauma Brain Injury (TBI) Database at Trondheim University Hospital
Taste And Smell TEsting in End Stage Renal Disease
Trial of Directed High-dose Nasal Steroids on Residual Smell Loss in Sinus Patients After Sinus Surgery
Is Pentoxifylline Able to Improve Olfactory Sensitivity?